Agrx stock earnings

Implied Volatility Surging for Agile Therapeutics (AGRX) Stock Options Zacks +7.20% Dec-19-19 04:05PM Agile Therapeutics to Present at Biotech Showcase 2020 in San Francisco GlobeNewswire +6.98%

Find the latest Agile Therapeutics, Inc. (AGRX) stock quote, history, news and other vital information to help you Earnings Date, May 18, 2020 - May 22, 2020. Agile Therapeutics Inc (NASDAQ:AGRX) The current consensus among 6 polled investment analysts is to Buy stock in Agile Earnings and Sales Forecasts  23 Mar 2020 Real-time trade and investing ideas on Agile Therapeutics AGRX from the largest community of traders and investors. Stock Information. NASDAQ: AGRX $1.68 -0.26 (0.00%). Copyright West LLC. Minimum 15 minutes delayed. Read More  20 Feb 2020 Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, warrants to purchase 1,400,000 shares of Agile common stock. Stock analysis for Agile Therapeutics Inc (AGRX:NASDAQ CM) including stock price, stock Earnings Announcement for Period Ending Q1/2020:05/01/2020 

AGRX: Agile Therapeutics Inc - Stock Price, Quote ... - CNBC

View the real-time AGRX price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Agile Therapeutics against related stocks people have also bought like ONTX, FCEL, ADXS, and OGEN. 20,328 people own Agile Therapeutics on Robinhood on April 4, 2020. Agile Therapeutics, Inc. (AGRX) Earnings Report | Seeking ... Agile Therapeutics, Inc. (AGRX) latest earnings report: revenue, EPS, surprise, history, news and analysis. AGRX - Agile Therap Stock Price - Barchart.com

Researching Agile Therapeutics (NASDAQ:AGRX) stock? View AGRX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.

GAAP vs. Non-GAAP Earnings. TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Agile Therapeutics, Inc. (Nasdaq: AGRX) to Ring Nasdaq ... Feb 26, 2020 · Agile Therapeutics, Inc. (Nasdaq: AGRX) to Ring Nasdaq Stock Market Closing Bell on Wednesday, February 26, 2020 HC Wainwright Trims Agile Therapeutics (NASDAQ:AGRX ...

Agile Therapeutics, Inc. (AGRX) Stock Price, Quote ...

Real time Agile Therapeutics (AGRX) stock price quote, stock graph, news & analysis. Sophisticated Investors Should Avoid: Agile Therapeutics ... Mar 13, 2020 · On November 29, 2018, Maxim Group recommended the AGRX stock is a Buy, while earlier, Janney had Resumed the stock as a Buy on April 12, 2019. 6 analysts offering the recommendations for the stock have a consensus rating of 1.50 to suggest that the AGRX stock is a “Strong Sell. 0 of the 6 analysts rate the stock as a “Sell”, while 0 has rated it as “Underweight”. 6 … Why Agile Therapeutics Stock Jumped Today | The Motley Fool Feb 11, 2020 · Earnings Call Transcripts; (NASDAQ:AGRX) were jumping 8.5% higher as of 3 p.m. EST on Tuesday after rising as much as 15.7% earlier in the … AGRX - Agile Therapeutics Summary, Stock Quote and News ...

23 Mar 2020 Real-time trade and investing ideas on Agile Therapeutics AGRX from the largest community of traders and investors.

Agile Therapeutics, Inc. (AGRX) latest earnings report: revenue, EPS, surprise, history, news and analysis. AGRX - Agile Therap Stock Price - Barchart.com Agile Therap (AGRX) Agile Therap (AGRX) [[ item.lastPrice ]] Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener. Barchart Trade Picks. Today's Top Stock Pick All Top Stock Picks. AGRX Stock News - Fidelity

Mar 30, 2020 · Agile Therapeutics, Inc. (AGRX), a women s healthcare company, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The joint book-running managers for the offering are RBC Capital Markets, William Blair and Oppenheimer & Co. Agile Therapeutics, Inc. Revenue & Earnings ... - NASDAQ.com Agile Therapeutics, Inc. (AGRX) Revenue, Earnings Per Share (EPS), & Dividend Get free financial information for Agile Therapeutics, Inc. including revenue, earnings per share (EPS), and company dividend at NASDAQ.com